TPB Soars: Net Sales Up 28%, Net Income Jumps 50% on Strong Q3

TL;DR

**TPB's Q3 numbers are smoking hot, showing strong growth and a cash pile-up despite regulatory headwinds – time to light up your portfolio!**

AI Summary

Turning Point Brands, Inc. (TPB) reported a robust financial performance for the nine months ended September 30, 2025, with net sales increasing significantly to $342.049 million from $266.993 million in the prior year, representing a 28.1% rise. Consolidated net income also saw a substantial jump to $56.508 million, up from $37.459 million in the same period of 2024, a 50.8% increase. Diluted earnings per share rose to $2.70 from $1.99. The company's cash position dramatically improved, with cash increasing to $201.189 million from $46.158 million at December 31, 2024, largely due to $300.000 million in proceeds from 2032 Notes and $97.499 million from an At-the-Market offering, partially offset by the redemption of $250.000 million in 2026 Notes. Total assets grew to $742.848 million from $493.353 million, while total liabilities increased to $384.695 million from $302.973 million, primarily due to higher notes payable and long-term debt. Key risks include declining tobacco sales, intense competition, and substantial FDA regulation, which could impact future product offerings and market access.

Why It Matters

This strong performance signals TPB's ability to navigate a challenging regulatory environment and competitive landscape, particularly in the tobacco and alternative products sector. For investors, the significant increase in net income and cash flow, coupled with strategic debt refinancing, suggests improved financial health and potential for future growth, making TPB a more attractive investment compared to competitors facing steeper declines. Employees benefit from a stable and growing company, while customers may see continued product innovation. The broader market will watch if TPB can sustain this momentum amidst ongoing FDA scrutiny and evolving consumer preferences, potentially setting a benchmark for other companies in the industry.

Risk Assessment

Risk Level: medium — The risk level is medium due to the company's dependence on declining tobacco product sales and substantial, increasing FDA regulation, as explicitly stated in the 'Cautionary Note Regarding Forward-Looking Statements'. While financial performance is strong, these external factors pose significant long-term threats to revenue streams and operational flexibility, potentially impacting future growth and profitability.

Analyst Insight

Investors should consider TPB's strong cash position and growth in net income as a positive indicator, but remain vigilant regarding regulatory developments from the FDA. Monitor the company's ability to diversify its product portfolio and adapt to changing consumer preferences to mitigate the inherent risks of the tobacco industry.

Financial Highlights

debt To Equity

1.07

revenue

$342.049M

operating Margin

22.0%

total Assets

$742.848M

total Debt

$293.364M

net Income

$56.508M

eps

$2.70

gross Margin

57.5%

cash Position

$201.189M

revenue Growth

+28.1%

Revenue Breakdown

Key Numbers

• $342.049M — Net Sales (Increased from $266.993M in 2024, a 28.1% rise for the nine months ended September 30, 2025.)
• $56.508M — Consolidated Net Income (Increased from $37.459M in 2024, a 50.8% increase for the nine months ended September 30, 2025.)
• $2.70 — Diluted EPS (Increased from $1.99 in 2024 for the nine months ended September 30, 2025.)
• $201.189M — Cash (Increased from $46.158M at December 31, 2024, a 335.9% increase.)
• $300.000M — Proceeds from 2032 Notes (Significant financing activity contributing to increased cash.)
• $97.499M — At-the-Market Offering Proceeds (Additional capital raised through equity issuance.)
• $250.000M — Redemption of 2026 Notes (Debt management activity.)
• $742.848M — Total Assets (Increased from $493.353M at December 31, 2024.)
• $384.695M — Total Liabilities (Increased from $302.973M at December 31, 2024.)
• 19,070,757 — Shares Outstanding (As of October 31, 2025, indicating shareholder base.)

Key Players & Entities

• Turning Point Brands, Inc. (company) — registrant
• FDA (regulator) — U.S. Food and Drug Administration
• $342.049 million (dollar_amount) — net sales for nine months ended September 30, 2025
• $266.993 million (dollar_amount) — net sales for nine months ended September 30, 2024
• $56.508 million (dollar_amount) — consolidated net income for nine months ended September 30, 2025
• $37.459 million (dollar_amount) — consolidated net income for nine months ended September 30, 2024
• $2.70 (dollar_amount) — diluted earnings per share for nine months ended September 30, 2025
• $1.99 (dollar_amount) — diluted earnings per share for nine months ended September 30, 2024
• $201.189 million (dollar_amount) — cash at September 30, 2025
• $46.158 million (dollar_amount) — cash at December 31, 2024

FAQ

Risk Factors

• FDA Regulation Impact [high — regulatory]: Substantial Food and Drug Administration (FDA) regulation poses a significant risk, potentially impacting future product offerings and market access. The company's ability to adapt to evolving regulatory landscapes is critical for sustained growth.
• Declining Tobacco Sales [medium — market]: The company faces the risk of declining sales in traditional tobacco products. This trend necessitates a strategic focus on next-generation products and diversification to mitigate revenue erosion.
• Intense Competition [medium — market]: The branded consumer products market, particularly in tobacco and related categories, is characterized by intense competition. Maintaining market share and profitability requires continuous innovation and effective marketing strategies.
• Debt Management [medium — financial]: The company has undertaken significant debt financing, including issuing $300 million in 2032 Notes and redeeming $250 million in 2026 Notes. Managing this debt structure and associated interest expenses is crucial.
• Supply Chain and Inventory Management [medium — operational]: With inventories increasing to $112.79 million from $96.25 million, effective supply chain and inventory management are vital to avoid obsolescence and manage working capital efficiently.

Industry Context

Turning Point Brands operates in the branded consumer products sector, with a significant focus on tobacco and related accessories. The industry is characterized by established brands, evolving consumer preferences towards next-generation products, and intense competition. Regulatory scrutiny, particularly from the FDA, is a constant factor shaping product development and market access.

Regulatory Implications

The company faces significant regulatory risks from the FDA, which could impact its product portfolio and distribution channels. Compliance with evolving regulations is paramount, and any adverse changes could materially affect future sales and profitability.

What Investors Should Do

1. Monitor FDA regulatory developments closely.
2. Analyze the impact of debt financing on future profitability.
3. Evaluate the growth drivers within the Zig-Zag and Stoker's segments.
4. Assess the company's strategy for addressing declining traditional tobacco sales.

Key Dates

• 2025-09-30: Nine months ended September 30, 2025 — Reporting period showing significant revenue and net income growth.
• 2025-01-02: Divestiture of Creative Distribution Solutions (CDS) — Streamlined operations to focus on core Zig-Zag and Stoker's segments.
• 2025-10-31: Shares Outstanding — 19,070,757 shares outstanding, indicating the current shareholder base.
• 2032-XX-XX: 2032 Notes Issuance — Raised $300 million, significantly boosting cash reserves and impacting the company's debt structure.
• 2026-XX-XX: 2026 Notes Redemption — Repaid $250 million in debt, part of active debt management.

Glossary

Master Settlement Agreement (MSA) escrow deposits

Funds set aside by tobacco companies as part of legal settlements, typically to cover future payments or obligations. (Represents a significant non-current asset for TPB, indicating potential future liabilities or commitments related to tobacco industry settlements.)

At-the-Market (ATM) offering

A type of equity offering where a company sells shares directly into the open market over a period of time at prevailing market prices. (TPB raised $97.499 million through an ATM offering, indicating a method of capital raising that dilutes existing shareholders but provides immediate liquidity.)

Non-controlling interest

The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership stake of outside shareholders. (The increase in non-controlling interest from $2.399 million to $14.203 million suggests TPB may have acquired a larger stake in a subsidiary or that a subsidiary's profitability has increased, impacting consolidated equity.)

Cost of repurchased common stock

The amount paid by a company to buy back its own shares from the open market, reducing the number of outstanding shares. (TPB reduced its treasury stock by $35.507 million (from $83.144M to $47.637M), indicating a buyback of shares, which can increase EPS and shareholder value.)

Right of use assets

Assets recognized under lease accounting standards, representing the right to use an underlying asset for the lease term. (These assets, related to lease obligations, increased slightly, reflecting TPB's ongoing use of leased properties or equipment.)

Year-Over-Year Comparison

For the nine months ended September 30, 2025, Turning Point Brands demonstrated substantial growth compared to the same period in 2024. Net sales surged by 28.1% to $342.049 million, and net income saw an even more impressive increase of 50.8% to $56.508 million, leading to a higher diluted EPS of $2.70. This growth was accompanied by a significant strengthening of the balance sheet, with cash reserves more than quadrupling to $201.189 million, largely due to new debt issuance and equity offerings, while total assets and liabilities also increased.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value TPB New York Stock Exchan

Filing Documents

• tpb20250930c_10q.htm (10-Q) — 2825KB
• ex_852046.htm (EX-31.1) — 9KB
• ex_852047.htm (EX-31.2) — 9KB
• ex_852048.htm (EX-31.3) — 8KB
• ex_852049.htm (EX-32.1) — 8KB
• 0001437749-25-033374.txt ( ) — 12620KB
• tpb-20250930.xsd (EX-101.SCH) — 92KB
• tpb-20250930_cal.xml (EX-101.CAL) — 82KB
• tpb-20250930_def.xml (EX-101.DEF) — 582KB
• tpb-20250930_lab.xml (EX-101.LAB) — 552KB
• tpb-20250930_pre.xml (EX-101.PRE) — 640KB
• tpb20250930c_10q_htm.xml (XML) — 2520KB

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION ITEM 1

Financial Statements (Unaudited)

Financial Statements (Unaudited) Consolidated Balance Sheets as of September 30, 2025 , and December 31, 2024 5 Consolidated Statements of Income for the three and nine months ended September 30, 2025 and 2024 6 Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2025 and 2024 7 Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 8 Consolidated Statements of Changes in Stockholders ' Equity for the three months ended September 30, 2025 and 2024 9 Consolidated Statements of Changes in Stockholders ' Equity for the nine months ended September 30, 2025 and 2024 10

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 11 ITEM 2 Management ' s Discussion and Analysis of Financial Condition and Results of Operations 29 ITEM 3

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 44 ITEM 4

Controls and Procedures

Controls and Procedures 44

— OTHER INFORMATION

PART II — OTHER INFORMATION ITEM 1

Legal Proceedings

Legal Proceedings 45 ITEM 1A

Risk Factors

Risk Factors 45 ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 45 ITEM 3 Defaults Upon Senior Securities 45 ITEM 4 Mine Safety Disclosures 45 ITEM 5 Other Information 45 ITEM 6 Exhibits 46

Signatures

Signatures 47 Table of Contents Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 (this "Quarterly Report"), contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan," and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. ("TPB"), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to: declining sales of tobacco products, and expected continuing decline of sales in the tobacco industry overall; our dependence on a small number of third-party suppliers and producers; the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost; the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted; failure to maintain consumer brand

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Turning Point Brands, Inc. Consolidated Balance Sheets (dollars in thousands except share data) (unaudited) September 30, December 31, 2025 2024 ASSETS Current assets: Cash $ 201,189 $ 46,158 Accounts receivable, net of allowances of $ 174 in 2025 and $ 66 in 2024 27,792 9,624 Inventories, net 112,790 96,253 Current assets held for sale - 11,470 Other current assets 54,665 34,700 Total current assets 396,436 198,205 Property, plant, and equipment, net 33,880 26,337 Deferred tax assets, net - 995 Right of use assets 12,915 11,610 Deferred financing costs, net 1,341 1,823 Goodwill 136,068 135,932 Other intangible assets, net 64,344 65,254 Master Settlement Agreement (MSA) escrow deposits 29,762 28,676 Noncurrent assets held for sale - 3,859 Other assets 68,102 20,662 Total assets $ 742,848 $ 493,353 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 24,599 $ 11,675 Accrued liabilities 46,738 31,096 Current liabilities held for sale - 2,049 Total current liabilities 71,337 44,820 Deferred tax liabilities, net 3,971 - Notes payable and long-term debt 293,364 248,604 Other long-term liabilities 6,182 - Lease liabilities 9,841 9,549 Total liabilities $ 384,695 $ 302,973 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; authorized shares 40,000,000 ; issued and outstanding shares - 0 - - - Common stock, voting, $ 0.01 par value; authorized shares, 190,000,000 ; 20,527,900 issued shares and 19,070,757 outstanding shares at September 30, 2025, and 20,200,886 issued shares and 17,729,481 outstanding shares at December 31, 2024 216 202 Common stock, nonvoting, $ 0.01 par value; authorized shares, 10,000,000 ; issued and outstanding shares - 0 - - - Additional paid-in capital 200,376 126,662 Cost of repurchased common stock ( 1,457,143 shares at September 30, 2025 and 2,471,40

Notes to Consolidated Financial Statements (Unaudited)

Notes to Consolidated Financial Statements (Unaudited) (dollars in thousands, except where designated and per share data) Note 1. Business and Basis of Presentation Description of Business Turning Point Brands, Inc., including its subsidiaries (collectively referred to herein as the "Company," "we," "our" or "us"), is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag and Stoker ' s and its next generation products to fulfill evolving consumer preferences. The Company operates two segments, Zig-Zag products and Stoker's products, led by its core proprietary and iconic brands: Zig-Zag and Stoker ' s along with FRE , Beech-Nut and Trophy . The Company's products are available in more than 220,000 retail outlets in North America. Discontinued Operations On January 2, 2025, the Company contributed 100 % of its interest in South Beach Brands LLC ("SBB"), the subsidiary that owned and operated the Company's former Creative Distribution Solutions ("CDS") reportable segment, to General Wireless Operations, Inc. ("GWO") in exchange for 49 % of the issued and outstanding GWO common stock. GWO is a joint venture between the Company and Standard General, LP entered into in December 2018. As of December 31, 2024, the assets and liabilities associated with the CDS segment have been classified as held for sale. Accordingly, the financial results of the CDS segment were classified as discontinued operations and reported separately for all periods presented herein until its disposition on January 2, 2025. Following the discontinued operations classification, the Company has two reportable segments, which are reflected herein. Unless otherwise noted, disclosures in the notes to these consolidated financial statements relate solely to the Company's continuing operations, comprised of the Zig-Zag and Stoker's segments. See N

View Full Filing

View this 10-Q filing on SEC EDGAR